High-dose vitamin D may not be better than low-dose vitamin D in treating multiple sclerosis

Low vitamin D levels are associated with an increased risk of developing multiple sclerosis (MS), but the first randomized, controlled trial using high-dose vitamin D in MS did not find any added benefit over and above ongoing low-dose vitamin D supplementation, according to a new study.

Read the whole article on Science Daily

More from Science Daily